Home › Neurologic Diseases › Ohio › Cincinnati
Neurologic Diseases clinical trials in Cincinnati, OH
5 studies for Neurologic Diseases are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- Cincinnati, Ohio, Cincinnati
Product Surveillance Registry
RecruitingObservational study
- Edgewood, Edgewood · 8 mi away
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, West Chester · 15 mi away
Rett Syndrome Registry
RecruitingObservational study
- Cincinnati Children's Hospital Medical Center, Cincinnati
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- Cincinnati Children's Hospital Comprehensive Epilepsy Center (CCHMC), Cincinnati
- University of Cincinnati Gardner Neuroscience Institute Epilepsy Center, Cincinnati
About Neurologic Diseases
Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.
More about Neurologic Diseases on MedlinePlus
Neurologic Diseases trials in other cities
- Boston, MA10 studies
- Washington, DC8 studies
- Miami, FL7 studies
- Philadelphia, PA7 studies
- Orlando, FL7 studies
- Dallas, TX7 studies
- St. Louis, MO6 studies
- Houston, TX6 studies
- San Diego, CA6 studies
- New York City, NY6 studies
- Chicago, IL6 studies
- Pittsburgh, PA5 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)27 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Lung Cancer19 studies
- Obesity19 studies
- Prostate Cancer18 studies
- Multiple Myeloma17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.